Form 4: SANUWAVE Health Executive VP Granted Stock Options

Timothy Hendricks, Executive VP of Sales at SANUWAVE Health, Inc., was granted stock options for 50,667 shares on October 22, 2024.

Summary

• Timothy Hendricks, Executive VP of Sales at SANUWAVE Health, Inc., received stock options on October 22, 2024.
• The options grant covers 50,667 shares of common stock.
• The exercise price of the options is $14.20.
• The options vest in 12 equal quarterly installments over three years, starting from the grant date.
• The options expire on October 22, 2034.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to executive compensation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The granting of stock options to a key executive aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Stock option grants are a common form of executive compensation in the healthcare industry, used to incentivize performance and retain key personnel.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages across various industries, including healthcare.
• The vesting schedule of three years with quarterly installments is a typical structure to ensure long-term commitment.
• The size of the grant (50,667 shares) would need to be compared to grants given to executives with similar roles at comparable companies to assess its relative value.

Stakeholder Impact

• The stock option grant could potentially dilute existing shareholders if the options are exercised.
• The grant incentivizes the executive to improve company performance, which could benefit shareholders, employees, and other stakeholders.

Key Dates